: Medicare drug price negotiations move forward with all drugmakers participating, White House says
Read Time:3 Second
Novo Nordisk is latest drugmaker to challenge negotiation program in court.
GimmeCredit started coverage of Qualcomm’s bonds Wednesday with a bearish rating.
Some U.S. auto makers are more vulnerable to increased competition from China and face market-share loss, analysts at Morgan Stanley...
With demand for the use of artificial intelligence expected to continue to surge, Oppenheimer analyst Edward Yang recommended investors buy...
Fines follow probe of Harvest’s Collateral Yield Enhancement Strategy (CYES).
New-home sales fell in August, but still beat estimates.
Nearly 80% of workers say they don’t know much about their finances.